 | • レポートコード：MRC2-11QY11375 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はチャーグ・ストラウス症候群のグローバル市場について調査・分析したレポートです。種類別（生物製剤、免疫グロブリン、ワクチン、ステロイド、その他）市場規模、用途別（研究所、病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別チャーグ・ストラウス症候群の競争状況、市場シェア ・世界のチャーグ・ストラウス症候群市場：種類別市場規模 2015年-2020年（生物製剤、免疫グロブリン、ワクチン、ステロイド、その他） ・世界のチャーグ・ストラウス症候群市場：種類別市場規模予測 2021年-2026年（生物製剤、免疫グロブリン、ワクチン、ステロイド、その他） ・世界のチャーグ・ストラウス症候群市場：用途別市場規模 2015年-2020年（研究所、病院、クリニック、その他） ・世界のチャーグ・ストラウス症候群市場：用途別市場規模予測 2021年-2026年（研究所、病院、クリニック、その他） ・北米のチャーグ・ストラウス症候群市場分析：米国、カナダ ・ヨーロッパのチャーグ・ストラウス症候群市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのチャーグ・ストラウス症候群市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のチャーグ・ストラウス症候群市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのチャーグ・ストラウス症候群市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Heron Therapeutic、IRX Therapeutic、Brabourne Enterprises、Tianjin Tianyao Pharmaceuticals、Grifols ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Churg Strauss syndrome is a disorder that causes inflammation in blood vessels. This restricts the blood flow to vital organs and tissues. Sometimes it leads to permanent damage of tissues. This condition is also known as eosinophilic granulomatosis with polyangiitis. Asthma is the most common sign of churg Strauss syndrome. It also affects nose, sinuses, lung, heart, and nerves.
Factors such as growing occurrences of churg Strauss syndrome and other allergic reactions and asthma, rising geriatric population, and growing incidences of churg Strauss syndrome in children are expected to drive the growth of the market during the assessment period.
Market Analysis and Insights: Global Churg Strauss Syndrome Market
The global Churg Strauss Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Churg Strauss Syndrome Scope and Market Size
Churg Strauss Syndrome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Churg Strauss Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Heron Therapeutic
IRX Therapeutic
Brabourne Enterprises
Tianjin Tianyao Pharmaceuticals
Grifols
…
Market segment by Type, the product can be split into
Biologics
Immunoglobulin
Vaccines
Steroid
Others
Market segment by Application, split into
Laboratories
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Churg Strauss Syndrome Revenue
1.4 Market by Type
1.4.1 Global Churg Strauss Syndrome Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biologics
1.4.3 Immunoglobulin
1.4.4 Vaccines
1.4.5 Steroid
1.4.6 Others
1.5 Market by Application
1.5.1 Global Churg Strauss Syndrome Market Share by Application: 2020 VS 2026
1.5.2 Laboratories
1.5.3 Hospitals
1.5.4 Clinics
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Churg Strauss Syndrome Market Perspective (2015-2026)
2.2 Global Churg Strauss Syndrome Growth Trends by Regions
2.2.1 Churg Strauss Syndrome Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Churg Strauss Syndrome Historic Market Share by Regions (2015-2020)
2.2.3 Churg Strauss Syndrome Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Churg Strauss Syndrome Market Growth Strategy
2.3.6 Primary Interviews with Key Churg Strauss Syndrome Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Churg Strauss Syndrome Players by Market Size
3.1.1 Global Top Churg Strauss Syndrome Players by Revenue (2015-2020)
3.1.2 Global Churg Strauss Syndrome Revenue Market Share by Players (2015-2020)
3.1.3 Global Churg Strauss Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Churg Strauss Syndrome Market Concentration Ratio
3.2.1 Global Churg Strauss Syndrome Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Churg Strauss Syndrome Revenue in 2019
3.3 Churg Strauss Syndrome Key Players Head office and Area Served
3.4 Key Players Churg Strauss Syndrome Product Solution and Service
3.5 Date of Enter into Churg Strauss Syndrome Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Churg Strauss Syndrome Historic Market Size by Type (2015-2020)
4.2 Global Churg Strauss Syndrome Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Churg Strauss Syndrome Market Size by Application (2015-2020)
5.2 Global Churg Strauss Syndrome Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Churg Strauss Syndrome Market Size (2015-2020)
6.2 Churg Strauss Syndrome Key Players in North America (2019-2020)
6.3 North America Churg Strauss Syndrome Market Size by Type (2015-2020)
6.4 North America Churg Strauss Syndrome Market Size by Application (2015-2020)
7 Europe
7.1 Europe Churg Strauss Syndrome Market Size (2015-2020)
7.2 Churg Strauss Syndrome Key Players in Europe (2019-2020)
7.3 Europe Churg Strauss Syndrome Market Size by Type (2015-2020)
7.4 Europe Churg Strauss Syndrome Market Size by Application (2015-2020)
8 China
8.1 China Churg Strauss Syndrome Market Size (2015-2020)
8.2 Churg Strauss Syndrome Key Players in China (2019-2020)
8.3 China Churg Strauss Syndrome Market Size by Type (2015-2020)
8.4 China Churg Strauss Syndrome Market Size by Application (2015-2020)
9 Japan
9.1 Japan Churg Strauss Syndrome Market Size (2015-2020)
9.2 Churg Strauss Syndrome Key Players in Japan (2019-2020)
9.3 Japan Churg Strauss Syndrome Market Size by Type (2015-2020)
9.4 Japan Churg Strauss Syndrome Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Churg Strauss Syndrome Market Size (2015-2020)
10.2 Churg Strauss Syndrome Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Churg Strauss Syndrome Market Size by Type (2015-2020)
10.4 Southeast Asia Churg Strauss Syndrome Market Size by Application (2015-2020)
11 India
11.1 India Churg Strauss Syndrome Market Size (2015-2020)
11.2 Churg Strauss Syndrome Key Players in India (2019-2020)
11.3 India Churg Strauss Syndrome Market Size by Type (2015-2020)
11.4 India Churg Strauss Syndrome Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Churg Strauss Syndrome Market Size (2015-2020)
12.2 Churg Strauss Syndrome Key Players in Central & South America (2019-2020)
12.3 Central & South America Churg Strauss Syndrome Market Size by Type (2015-2020)
12.4 Central & South America Churg Strauss Syndrome Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Heron Therapeutic
13.1.1 Heron Therapeutic Company Details
13.1.2 Heron Therapeutic Business Overview
13.1.3 Heron Therapeutic Churg Strauss Syndrome Introduction
13.1.4 Heron Therapeutic Revenue in Churg Strauss Syndrome Business (2015-2020))
13.1.5 Heron Therapeutic Recent Development
13.2 IRX Therapeutic
13.2.1 IRX Therapeutic Company Details
13.2.2 IRX Therapeutic Business Overview
13.2.3 IRX Therapeutic Churg Strauss Syndrome Introduction
13.2.4 IRX Therapeutic Revenue in Churg Strauss Syndrome Business (2015-2020)
13.2.5 IRX Therapeutic Recent Development
13.3 Brabourne Enterprises
13.3.1 Brabourne Enterprises Company Details
13.3.2 Brabourne Enterprises Business Overview
13.3.3 Brabourne Enterprises Churg Strauss Syndrome Introduction
13.3.4 Brabourne Enterprises Revenue in Churg Strauss Syndrome Business (2015-2020)
13.3.5 Brabourne Enterprises Recent Development
13.4 Tianjin Tianyao Pharmaceuticals
13.4.1 Tianjin Tianyao Pharmaceuticals Company Details
13.4.2 Tianjin Tianyao Pharmaceuticals Business Overview
13.4.3 Tianjin Tianyao Pharmaceuticals Churg Strauss Syndrome Introduction
13.4.4 Tianjin Tianyao Pharmaceuticals Revenue in Churg Strauss Syndrome Business (2015-2020)
13.4.5 Tianjin Tianyao Pharmaceuticals Recent Development
13.5 Grifols
13.5.1 Grifols Company Details
13.5.2 Grifols Business Overview
13.5.3 Grifols Churg Strauss Syndrome Introduction
13.5.4 Grifols Revenue in Churg Strauss Syndrome Business (2015-2020)
13.5.5 Grifols Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Churg Strauss Syndrome Key Market Segments
Table 2. Key Players Covered: Ranking by Churg Strauss Syndrome Revenue
Table 3. Ranking of Global Top Churg Strauss Syndrome Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Churg Strauss Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biologics
Table 6. Key Players of Immunoglobulin
Table 7. Key Players of Vaccines
Table 8. Key Players of Steroid
Table 9. Key Players of Others
Table 10. Global Churg Strauss Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Churg Strauss Syndrome Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Churg Strauss Syndrome Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Churg Strauss Syndrome Market Share by Regions (2015-2020)
Table 14. Global Churg Strauss Syndrome Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Churg Strauss Syndrome Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Churg Strauss Syndrome Market Growth Strategy
Table 20. Main Points Interviewed from Key Churg Strauss Syndrome Players
Table 21. Global Churg Strauss Syndrome Revenue by Players (2015-2020) (Million US$)
Table 22. Global Churg Strauss Syndrome Market Share by Players (2015-2020)
Table 23. Global Top Churg Strauss Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Churg Strauss Syndrome as of 2019)
Table 24. Global Churg Strauss Syndrome by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Churg Strauss Syndrome Product Solution and Service
Table 27. Date of Enter into Churg Strauss Syndrome Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Churg Strauss Syndrome Market Size by Type (2015-2020) (Million US$)
Table 30. Global Churg Strauss Syndrome Market Size Share by Type (2015-2020)
Table 31. Global Churg Strauss Syndrome Revenue Market Share by Type (2021-2026)
Table 32. Global Churg Strauss Syndrome Market Size Share by Application (2015-2020)
Table 33. Global Churg Strauss Syndrome Market Size by Application (2015-2020) (Million US$)
Table 34. Global Churg Strauss Syndrome Market Size Share by Application (2021-2026)
Table 35. North America Key Players Churg Strauss Syndrome Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Churg Strauss Syndrome Market Share (2019-2020)
Table 37. North America Churg Strauss Syndrome Market Size by Type (2015-2020) (Million US$)
Table 38. North America Churg Strauss Syndrome Market Share by Type (2015-2020)
Table 39. North America Churg Strauss Syndrome Market Size by Application (2015-2020) (Million US$)
Table 40. North America Churg Strauss Syndrome Market Share by Application (2015-2020)
Table 41. Europe Key Players Churg Strauss Syndrome Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Churg Strauss Syndrome Market Share (2019-2020)
Table 43. Europe Churg Strauss Syndrome Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Churg Strauss Syndrome Market Share by Type (2015-2020)
Table 45. Europe Churg Strauss Syndrome Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Churg Strauss Syndrome Market Share by Application (2015-2020)
Table 47. China Key Players Churg Strauss Syndrome Revenue (2019-2020) (Million US$)
Table 48. China Key Players Churg Strauss Syndrome Market Share (2019-2020)
Table 49. China Churg Strauss Syndrome Market Size by Type (2015-2020) (Million US$)
Table 50. China Churg Strauss Syndrome Market Share by Type (2015-2020)
Table 51. China Churg Strauss Syndrome Market Size by Application (2015-2020) (Million US$)
Table 52. China Churg Strauss Syndrome Market Share by Application (2015-2020)
Table 53. Japan Key Players Churg Strauss Syndrome Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Churg Strauss Syndrome Market Share (2019-2020)
Table 55. Japan Churg Strauss Syndrome Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Churg Strauss Syndrome Market Share by Type (2015-2020)
Table 57. Japan Churg Strauss Syndrome Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Churg Strauss Syndrome Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Churg Strauss Syndrome Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Churg Strauss Syndrome Market Share (2019-2020)
Table 61. Southeast Asia Churg Strauss Syndrome Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Churg Strauss Syndrome Market Share by Type (2015-2020)
Table 63. Southeast Asia Churg Strauss Syndrome Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Churg Strauss Syndrome Market Share by Application (2015-2020)
Table 65. India Key Players Churg Strauss Syndrome Revenue (2019-2020) (Million US$)
Table 66. India Key Players Churg Strauss Syndrome Market Share (2019-2020)
Table 67. India Churg Strauss Syndrome Market Size by Type (2015-2020) (Million US$)
Table 68. India Churg Strauss Syndrome Market Share by Type (2015-2020)
Table 69. India Churg Strauss Syndrome Market Size by Application (2015-2020) (Million US$)
Table 70. India Churg Strauss Syndrome Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Churg Strauss Syndrome Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Churg Strauss Syndrome Market Share (2019-2020)
Table 73. Central & South America Churg Strauss Syndrome Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Churg Strauss Syndrome Market Share by Type (2015-2020)
Table 75. Central & South America Churg Strauss Syndrome Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Churg Strauss Syndrome Market Share by Application (2015-2020)
Table 77. Heron Therapeutic Company Details
Table 78. Heron Therapeutic Business Overview
Table 79. Heron Therapeutic Product
Table 80. Heron Therapeutic Revenue in Churg Strauss Syndrome Business (2015-2020) (Million US$)
Table 81. Heron Therapeutic Recent Development
Table 82. IRX Therapeutic Company Details
Table 83. IRX Therapeutic Business Overview
Table 84. IRX Therapeutic Product
Table 85. IRX Therapeutic Revenue in Churg Strauss Syndrome Business (2015-2020) (Million US$)
Table 86. IRX Therapeutic Recent Development
Table 87. Brabourne Enterprises Company Details
Table 88. Brabourne Enterprises Business Overview
Table 89. Brabourne Enterprises Product
Table 90. Brabourne Enterprises Revenue in Churg Strauss Syndrome Business (2015-2020) (Million US$)
Table 91. Brabourne Enterprises Recent Development
Table 92. Tianjin Tianyao Pharmaceuticals Company Details
Table 93. Tianjin Tianyao Pharmaceuticals Business Overview
Table 94. Tianjin Tianyao Pharmaceuticals Product
Table 95. Tianjin Tianyao Pharmaceuticals Revenue in Churg Strauss Syndrome Business (2015-2020) (Million US$)
Table 96. Tianjin Tianyao Pharmaceuticals Recent Development
Table 97. Grifols Company Details
Table 98. Grifols Business Overview
Table 99. Grifols Product
Table 100. Grifols Revenue in Churg Strauss Syndrome Business (2015-2020) (Million US$)
Table 101. Grifols Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Churg Strauss Syndrome Market Share by Type: 2020 VS 2026
Figure 2. Biologics Features
Figure 3. Immunoglobulin Features
Figure 4. Vaccines Features
Figure 5. Steroid Features
Figure 6. Others Features
Figure 7. Global Churg Strauss Syndrome Market Share by Application: 2020 VS 2026
Figure 8. Laboratories Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Churg Strauss Syndrome Report Years Considered
Figure 13. Global Churg Strauss Syndrome Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Churg Strauss Syndrome Market Share by Regions: 2020 VS 2026
Figure 15. Global Churg Strauss Syndrome Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Churg Strauss Syndrome Market Share by Players in 2019
Figure 18. Global Top Churg Strauss Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Churg Strauss Syndrome as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Churg Strauss Syndrome Revenue in 2019
Figure 20. North America Churg Strauss Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Churg Strauss Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Churg Strauss Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Churg Strauss Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Churg Strauss Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Churg Strauss Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Churg Strauss Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
カルチノイド症候群管理の世界市場（～2026年） Carcinoid syndrome comprises of signs and symptoms including flushing of the face, debilitating diarrhea, asthma caused due to vasoconstriction, intestinal bleeding, fast heartbeat, shortness of breath, sweating, unexplained weight gain etc. which are settled secondary to carcinoid tumor. The manage…- バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…
- バーター症候群治療の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…
- セロトニン症候群の世界市場（～2026年） Serotonin syndrome is a group of symptoms such as high body temperature, agitation, increased reflexes, tremor, sweating, dilated pupils, diarrhoea etc. due to use of serotonergic drugs. Serious complications such as seizures and extensive muscle breakdown may occur which may lead to death. US accou…
- カルチノイド症候群下痢治療の世界市場（～2026年） Carcinoid syndrome is a group of symptoms that can occur in patients suffering from carcinoid tumors which also called as metastatic neuroendocrine tumors. Carcinoid tumors are rare and these are slow growing tumors. Most of the tumors occur in gastrointestinal tract. According to FDA, carcinoid syn…